Transdermal Patch-Global Market Status and Trend Report 2015-2026
Report Summary
Transdermal Patch-Global Market Status and Trend Report 2015-2026 offers a comprehensive analysis on Transdermal Patch industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Transdermal Patch 2015-2019, and development forecast 2020-2026
Main manufacturers/suppliers of Transdermal Patch worldwide, with company and product introduction, position in the Transdermal Patch market
Market status and development trend of Transdermal Patch by types and applications
Cost and profit status of Transdermal Patch, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Transdermal Patch market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Transdermal Patch industry.
The report segments the global Transdermal Patch market as:
Global Transdermal Patch Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2015-2026):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Transdermal Patch Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2015-2026):
Methyl Salicylate-Based Patch
Rivastigmine Patch
Fentanyl Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Patch
Others
Global Transdermal Patch Market: Application Segment Analysis (Consumption Volume and Market Share 2015-2026; Downstream Customers and Market Analysis)
Rx Channel
OTC Channel
Global Transdermal Patch Market: Manufacturers Segment Analysis (Company and Product introduction, Transdermal Patch Sales Volume, Revenue, Price and Gross Margin):
Hisamitsu Pharmaceutical
Gr?nenthal
UCB Pharma
Johnson & Johnson
Nitto Denko
Novartis
GSK
Teva Pharmaceutical
Mylan
IBSA Group
Bayer
Beijing Tide Pharmaceutical
Luye Pharma Group
Mundipharma
Dr Reddy’s Laboratories
Pfizer
Endo International
Chattem
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Transdermal Patch-Global Market Status and Trend Report 2015-2026 offers a comprehensive analysis on Transdermal Patch industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Transdermal Patch 2015-2019, and development forecast 2020-2026
Main manufacturers/suppliers of Transdermal Patch worldwide, with company and product introduction, position in the Transdermal Patch market
Market status and development trend of Transdermal Patch by types and applications
Cost and profit status of Transdermal Patch, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Transdermal Patch market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Transdermal Patch industry.
The report segments the global Transdermal Patch market as:
Global Transdermal Patch Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2015-2026):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Transdermal Patch Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2015-2026):
Methyl Salicylate-Based Patch
Rivastigmine Patch
Fentanyl Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Patch
Others
Global Transdermal Patch Market: Application Segment Analysis (Consumption Volume and Market Share 2015-2026; Downstream Customers and Market Analysis)
Rx Channel
OTC Channel
Global Transdermal Patch Market: Manufacturers Segment Analysis (Company and Product introduction, Transdermal Patch Sales Volume, Revenue, Price and Gross Margin):
Hisamitsu Pharmaceutical
Gr?nenthal
UCB Pharma
Johnson & Johnson
Nitto Denko
Novartis
GSK
Teva Pharmaceutical
Mylan
IBSA Group
Bayer
Beijing Tide Pharmaceutical
Luye Pharma Group
Mundipharma
Dr Reddy’s Laboratories
Pfizer
Endo International
Chattem
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF TRANSDERMAL PATCH
1.1 Definition of Transdermal Patch in This Report
1.2 Commercial Types of Transdermal Patch
1.2.1 Methyl Salicylate-Based Patch
1.2.2 Rivastigmine Patch
1.2.3 Fentanyl Patch
1.2.4 Lidocaine Patch
1.2.5 Diclofenac Patch
1.2.6 Nicotine Patch
1.2.7 Others
1.3 Downstream Application of Transdermal Patch
1.3.1 Rx Channel
1.3.2 OTC Channel
1.4 Development History of Transdermal Patch
1.5 Market Status and Trend of Transdermal Patch 2015-2026
1.5.1 Global Transdermal Patch Market Status and Trend 2015-2026
1.5.2 Regional Transdermal Patch Market Status and Trend 2015-2026
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Transdermal Patch 2015-2019
2.2 Production Market of Transdermal Patch by Regions
2.2.1 Production Volume of Transdermal Patch by Regions
2.2.2 Production Value of Transdermal Patch by Regions
2.3 Demand Market of Transdermal Patch by Regions
2.4 Production and Demand Status of Transdermal Patch by Regions
2.4.1 Production and Demand Status of Transdermal Patch by Regions 2015-2019
2.4.2 Import and Export Status of Transdermal Patch by Regions 2015-2019
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Transdermal Patch by Types
3.2 Production Value of Transdermal Patch by Types
3.3 Market Forecast of Transdermal Patch by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Transdermal Patch by Downstream Industry
4.2 Market Forecast of Transdermal Patch by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF TRANSDERMAL PATCH
5.1 Global Economy Situation and Trend Overview
5.2 Transdermal Patch Downstream Industry Situation and Trend Overview
CHAPTER 6 TRANSDERMAL PATCH MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Transdermal Patch by Major Manufacturers
6.2 Production Value of Transdermal Patch by Major Manufacturers
6.3 Basic Information of Transdermal Patch by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Transdermal Patch Major Manufacturer
6.3.2 Employees and Revenue Level of Transdermal Patch Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 TRANSDERMAL PATCH MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Hisamitsu Pharmaceutical
7.1.1 Company profile
7.1.2 Representative Transdermal Patch Product
7.1.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Hisamitsu Pharmaceutical
7.2 Gr?nenthal
7.2.1 Company profile
7.2.2 Representative Transdermal Patch Product
7.2.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Gr?nenthal
7.3 UCB Pharma
7.3.1 Company profile
7.3.2 Representative Transdermal Patch Product
7.3.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of UCB Pharma
7.4 Johnson & Johnson
7.4.1 Company profile
7.4.2 Representative Transdermal Patch Product
7.4.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.5 Nitto Denko
7.5.1 Company profile
7.5.2 Representative Transdermal Patch Product
7.5.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Nitto Denko
7.6 Novartis
7.6.1 Company profile
7.6.2 Representative Transdermal Patch Product
7.6.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Novartis
7.7 GSK
7.7.1 Company profile
7.7.2 Representative Transdermal Patch Product
7.7.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of GSK
7.8 Teva Pharmaceutical
7.8.1 Company profile
7.8.2 Representative Transdermal Patch Product
7.8.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical
7.9 Mylan
7.9.1 Company profile
7.9.2 Representative Transdermal Patch Product
7.9.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Mylan
7.10 IBSA Group
7.10.1 Company profile
7.10.2 Representative Transdermal Patch Product
7.10.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of IBSA Group
7.11 Bayer
7.11.1 Company profile
7.11.2 Representative Transdermal Patch Product
7.11.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Bayer
7.12 Beijing Tide Pharmaceutical
7.12.1 Company profile
7.12.2 Representative Transdermal Patch Product
7.12.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Beijing Tide Pharmaceutical
7.13 Luye Pharma Group
7.13.1 Company profile
7.13.2 Representative Transdermal Patch Product
7.13.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Luye Pharma Group
7.14 Mundipharma
7.14.1 Company profile
7.14.2 Representative Transdermal Patch Product
7.14.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Mundipharma
7.15 Dr Reddy’s Laboratories
7.15.1 Company profile
7.15.2 Representative Transdermal Patch Product
7.15.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Dr Reddy’s Laboratories
7.16 Pfizer
7.17 Endo International
7.18 Chattem
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF TRANSDERMAL PATCH
8.1 Industry Chain of Transdermal Patch
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF TRANSDERMAL PATCH
9.1 Cost Structure Analysis of Transdermal Patch
9.2 Raw Materials Cost Analysis of Transdermal Patch
9.3 Labor Cost Analysis of Transdermal Patch
9.4 Manufacturing Expenses Analysis of Transdermal Patch
CHAPTER 10 MARKETING STATUS ANALYSIS OF TRANSDERMAL PATCH
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Transdermal Patch in This Report
1.2 Commercial Types of Transdermal Patch
1.2.1 Methyl Salicylate-Based Patch
1.2.2 Rivastigmine Patch
1.2.3 Fentanyl Patch
1.2.4 Lidocaine Patch
1.2.5 Diclofenac Patch
1.2.6 Nicotine Patch
1.2.7 Others
1.3 Downstream Application of Transdermal Patch
1.3.1 Rx Channel
1.3.2 OTC Channel
1.4 Development History of Transdermal Patch
1.5 Market Status and Trend of Transdermal Patch 2015-2026
1.5.1 Global Transdermal Patch Market Status and Trend 2015-2026
1.5.2 Regional Transdermal Patch Market Status and Trend 2015-2026
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Transdermal Patch 2015-2019
2.2 Production Market of Transdermal Patch by Regions
2.2.1 Production Volume of Transdermal Patch by Regions
2.2.2 Production Value of Transdermal Patch by Regions
2.3 Demand Market of Transdermal Patch by Regions
2.4 Production and Demand Status of Transdermal Patch by Regions
2.4.1 Production and Demand Status of Transdermal Patch by Regions 2015-2019
2.4.2 Import and Export Status of Transdermal Patch by Regions 2015-2019
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Transdermal Patch by Types
3.2 Production Value of Transdermal Patch by Types
3.3 Market Forecast of Transdermal Patch by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Transdermal Patch by Downstream Industry
4.2 Market Forecast of Transdermal Patch by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF TRANSDERMAL PATCH
5.1 Global Economy Situation and Trend Overview
5.2 Transdermal Patch Downstream Industry Situation and Trend Overview
CHAPTER 6 TRANSDERMAL PATCH MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Transdermal Patch by Major Manufacturers
6.2 Production Value of Transdermal Patch by Major Manufacturers
6.3 Basic Information of Transdermal Patch by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Transdermal Patch Major Manufacturer
6.3.2 Employees and Revenue Level of Transdermal Patch Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 TRANSDERMAL PATCH MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Hisamitsu Pharmaceutical
7.1.1 Company profile
7.1.2 Representative Transdermal Patch Product
7.1.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Hisamitsu Pharmaceutical
7.2 Gr?nenthal
7.2.1 Company profile
7.2.2 Representative Transdermal Patch Product
7.2.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Gr?nenthal
7.3 UCB Pharma
7.3.1 Company profile
7.3.2 Representative Transdermal Patch Product
7.3.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of UCB Pharma
7.4 Johnson & Johnson
7.4.1 Company profile
7.4.2 Representative Transdermal Patch Product
7.4.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.5 Nitto Denko
7.5.1 Company profile
7.5.2 Representative Transdermal Patch Product
7.5.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Nitto Denko
7.6 Novartis
7.6.1 Company profile
7.6.2 Representative Transdermal Patch Product
7.6.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Novartis
7.7 GSK
7.7.1 Company profile
7.7.2 Representative Transdermal Patch Product
7.7.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of GSK
7.8 Teva Pharmaceutical
7.8.1 Company profile
7.8.2 Representative Transdermal Patch Product
7.8.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical
7.9 Mylan
7.9.1 Company profile
7.9.2 Representative Transdermal Patch Product
7.9.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Mylan
7.10 IBSA Group
7.10.1 Company profile
7.10.2 Representative Transdermal Patch Product
7.10.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of IBSA Group
7.11 Bayer
7.11.1 Company profile
7.11.2 Representative Transdermal Patch Product
7.11.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Bayer
7.12 Beijing Tide Pharmaceutical
7.12.1 Company profile
7.12.2 Representative Transdermal Patch Product
7.12.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Beijing Tide Pharmaceutical
7.13 Luye Pharma Group
7.13.1 Company profile
7.13.2 Representative Transdermal Patch Product
7.13.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Luye Pharma Group
7.14 Mundipharma
7.14.1 Company profile
7.14.2 Representative Transdermal Patch Product
7.14.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Mundipharma
7.15 Dr Reddy’s Laboratories
7.15.1 Company profile
7.15.2 Representative Transdermal Patch Product
7.15.3 Transdermal Patch Sales, Revenue, Price and Gross Margin of Dr Reddy’s Laboratories
7.16 Pfizer
7.17 Endo International
7.18 Chattem
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF TRANSDERMAL PATCH
8.1 Industry Chain of Transdermal Patch
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF TRANSDERMAL PATCH
9.1 Cost Structure Analysis of Transdermal Patch
9.2 Raw Materials Cost Analysis of Transdermal Patch
9.3 Labor Cost Analysis of Transdermal Patch
9.4 Manufacturing Expenses Analysis of Transdermal Patch
CHAPTER 10 MARKETING STATUS ANALYSIS OF TRANSDERMAL PATCH
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
